A synthetic engineered antibody developed by MabVax Therapeutics that binds to solid tumor cells for cancer diagnostics and treatment received a U.S. patent. . . . → Read More: Patent Awarded for Cancer-Fighting Antibody
|
|||||
       |
 One comment - (Comments are closed)  Intellectual property  biomarkers, biomedical, biotechnology, cancer, clinical trials, life sciences, patent, pharmaceuticals, USPTO An investment fund raising its capital through crowdfunding began operations this week to back start-up enterprises developing digital health technologies. . . . → Read More: Crowdfunded Digital Health Investment Fund Launches 2 comments - (Comments are closed) Finance, Joint ventures/collaborations biomedical, computer science, crowdfunding, engineering, entrepreneurs, equity, investment, Israel, life sciences, medical device, physical sciences, software, university, venture capital Drug maker Eli Lilly and Company is continuing its collaboration with Infectious Disease Research Institute to discovery new drugs that treat tuberculosis. . . . → Read More: Lilly, Institute Partner on Tuberculosis Drug Discovery Comments are closed Finance, Joint ventures/collaborations biomedical, grant, life sciences, NIH, pharmaceuticals, preclinical The national organization of Blue Cross-Blue Shield health insurance providers is linking up with academic researchers to study outcomes of health care practices, including opioid abuse and cancer screenings. . . . → Read More: Health Insurance Group Forms Academic Research Network Comments are closed Joint ventures/collaborations biomedical, cancer, economics, health care, life sciences, pharmaceuticals, university An experimental drug that clears peptides associated with Alzheimer’s disease from the central nervous system was also shown to be safe for patients in an early clinical trial. . . . → Read More: Safety, Effects Shown in Drug Clearing Alzheimer’s Peptides Comments are closed New products, Regulations biomedical, biotechnology, chemistry, clinical trials, life sciences, pharmaceuticals, physical sciences Two companies partnering with Auburn University developed a synthetic virus to find and destroy tumor cells in a type of bone cancer in dogs. . . . → Read More: Synthetic Virus Created to Treat Cancer in Dogs Comments are closed Joint ventures/collaborations, New products biomedical, biotechnology, cancer, computer science, engineering, genomics, life sciences, pharmaceuticals, physical sciences, software, university An early clinical trial shows genetically engineered skin grafts help heal some open wounds and appear safe for individuals with a serious inherited skin disorder. . . . → Read More: Gene Therapy Shown Helpful with Inherited Skin Disease Comments are closed New products biomedical, biotechnology, clinical trials, genomics, life sciences, medical device, pharmaceuticals, university A clinic to provide cancer treatments that use a patient’s immune system cells engineered to fight cancer is open at the Fred Hutchinson Cancer Research Center in Seattle. . . . → Read More: Clinic Opens for Engineered T-Cell Cancer Therapies Comments are closed New products biomedical, biotechnology, cancer, clinical trials, genomics, licensing, life sciences, pharmaceuticals A chemical engineering group showed the feasibility of embedding sensors in common spinach plants that can detect and signal the presence of explosive chemicals in the soil. . . . → Read More: Spinach Enhanced to Detect Chemicals, Send Signals Comments are closed New products agriculture, biotechnology, chemistry, engineering, entrepreneurs, life sciences, materials science, physical sciences, university |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts